Develop, Partner, Acquire or Avoid: Where is Investment for Digital Pathology Headed?

2nd May 2023 – Imogen Fitt – Featured on itnonline.com

The digital pathology market today is rife with potential for investment and returns, potential for major shifts in competitive dynamics, and potential for vendors to have a real impact on the way pathologists work

News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest in December, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. There, discussions centered around the progress of the market and its inevitable future developments.